Ambulatory blood pressure and urinary albumin excretion in clinically healthy subjects

Hypertension

Volumn 32, Issue 1, 1998, Pages 71-77

  Clausen, Peter ^a   Jensen, Jan S ^b   Borch Johnsen, Knut ^b   Jensen, Gorm ^b   Feldt Rasmussen, Bo ^a  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

Albuminuria; Atherosclerosis; Blood pressure, ambulatory; Cardiovascular disease; Risk factors

Indexed keywords

SERUM ALBUMIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

EID: 0031878321     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.1.71     Document Type: Article

References (50)

1. Jarrett RJ, Viberti GC, Argyropoulus A, Hill RD, Mahmud U, Murrels TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med. 1984;1:17-19.
2. Messent JWC, Elliot TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int. 1992; 41:836-839.
3. Deckert T, Yokoyama H, Mathiesen E, Rønn B, Jensen T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen JS. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ. 1996;312:871-874.
4. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10-year observational follow-up study. BMJ. 1996;313:779-784.
5. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet. 1988;2:530-533.
6. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990; 300:297-300.
7. Kuusisto J, Mykkänen L, Pyorala K, Saakso M. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation. 1995;91:831-837.
8. Borch-Johnsen K, Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, for Dan-MONICA. Microalbuminuria: an independent novel risk factor for IHD in non-diabetic individuals. Diabetologia. 1997;40(suppl 1):A445. Abstract.
9. Parving H-H, Jensen HÆ, Mogensen CE, Evrin PE. Increased urinary albumin excretion rate in benign essential hypertension. Lancet. 1974;1: 1190-1192.
10. Ljungman S, Aurell M, Hartford M, Wikstrand J, Wilhelsen L, Berglund G. Blood pressure and renal function. Acta Med Scand. 1980;208:17-25.
11. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Clausen P, Appleyard M, Jensen G. Microalbuminuria and its relation to cardiovascular disease and risk factors: a population-based study of 1254 hypertensive individuals. J Hum Hypertens. 1997;11:727-732.
12. Redon J, Liao Y, Lozano JV, Miralles A, Baldo E, Cooper RS. Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens. 1994;7:801-807.
13. Olivarius N de F, Andreasen AH, Keiding N, Mogensen CE. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients: cross-sectional data from the population-based study "Diabetes Care in General Practice," Denmark. Diabetologia. 1993;36: 1007-1016.
14. Christensen CK, Mogensen CE. The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabet Med. 1985;2:97-102.
15. Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in people at least 40 years old: effect of obesity, hypertension and hyperlipidemia. Clin Chem. 1992;38:1802-1808.
16. Vestbo E, Damsgaard EM, Frøland A, Mogensen CE. Microalbuminuria in a population based cohort. Diabet Med. 1995;12:488-493.
17. Pedersen EB, Mogensen CE. Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension. Scand J Clin Lab Invest. 1976;36:231-237.
18. Erley CM, Haefele U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension: reduction by different antihypertensive drugs. Hypertension. 1993;21:810-815.
19. Haffner SM, Stern MP, Gruber MKK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria: potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis. 1990;10: 727-731.
20. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis. 1995;112:245-256.
21. Millar-Craig MW, Bishop CN, Raftery EB. Diurnal variation of blood pressure. Lancet. 1979;1:795-797.
22. Mancia G. Presidential Lecture: ambulatory blood pressure monitoring -research and clinical applications. J Hypertens. 1990;8(suppl 7):S1-S13.
23. Perloff D, Solokow M, Cowan RM, Juster RP. Prognostic value of ambulatory measurements: further analyses. J Hypertens. 1989;7(suppl 3):S3-S10.
24. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
25. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;16:491-497.
26. Opshal JA, Abraham PA, Haltenson CHE, Keane WF. Correlation of office and ambulatory blood pressure measurements with urinary albumin and n-acetyl-β-d-glucosaminidase excretions in essential hypertension. Am J Hypertens. 1988;1:117S-120S.
27. Hansen KW, Christensen CK, Andersen PH, Pedersen MM, Christiansen JS, Mogensen CE. Ambulatory blood pressure in microalbuminuric type 1 diabetic patients. Kidney Int. 1992;41:847-854.
28. Gilbert RE, Phillips P, Jerums G. Relationship between ambulatory blood pressure and albuminuria in normal subjects. Am J Hypertens. 1991;4: 959-962.
29. Lindsay RS, Stewart MJ, Nairn IM, Baird JD, Padfield PL. Reduced diurnal variation of blood pressure in non-insulin-dependent diabetic patients with microalbuminuria. J Hum Hypertens. 1995;9:223-227.
30. Hansen KW, Mau Pedersen M, Marshall SM, Christiansen JS, Mogensen CE. Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia. 1992;35:1074-1079.
31. Copenhagen City Heart Study Group. The Copenhagen City Heart Study: a book of tables with data from the first examination (1976-78 and a five-year follow-up (1981-83). Scand J Soc Med. 1989;170(suppl 41): 1-160.
32. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G, for the Copenhagen City Heart Study Group. Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects. Scand J Clin Lab Invest. 1993;53:867-872.
33. Jensen JS. Intra-individual variation of overnight urinary albumin excretion in clinically healthy middle aged individuals. Clin Chim Acta. 1995;243:95-99.
34. Feldt-Rasmussen B, Dinesen B, Decken M. Enzyme immunoassay: an improved determination of urinary albumin excretion in diabetics with incipient nephropathy. Scand J Clin Lab Invest. 1985;45:539-544.
35. Krönig B. Ambulatory blood pressure measuring devices. Z Kardiol. 1996;85(suppl 3):32-37.
36. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campase VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens. 1994;7:23-29.
37. White WB. Relevance of the trough-to-peak ratio to the 24 h blood pressure load. Am J Hypertens. 1996;9:915-965.
38. Decken T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia. 1989;32:219-226.
39. Mann S, Altman DG, Raftery EB, Bannister R. Circadian variation of blood pressure in autonomic failure. Circulation. 1983;68:477-483.
40. Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens. 1991;4:20-26.
41. Tarazi RC, Magrini F, Dustan HP. The role of aortic distensibility in hypertension. In: Milliez P, Safar M, eds. Recent Advances in Hypertension, Vol 2. Reims, France: Societé Alinea: 1975:133-142.
42. Fineberg MH. Systolic hypertension: its relationship to atherosclerosis of the aorta and larger arteries. Am J Med Sci. 1927;173:835-842.
43. Pedrinelli R, Lindpaintner K, Dell'omo G, Napoli V, Di Bello V, De Caterina R, Petrucci R. Urinary albumin excretion and atherosclerosis in essential hypertension. Clin Sci. 1997;92:45-50.
44. Witteman JCM, Kok FJ, Saase van JLCM, Valkenburg HA. Aortic calcification as a predictor of cardiovascular mortality. Lancet. 1986;2: 1120-1122.
45. Bots ML, Witteman JCM, Grobbee DE. Carotid intima-media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta. Atherosclerosis. 1993;102:99-105.
46. Gosling P, Beevers DG. Urinary albumin excretion and blood pressure in the general population. Clin Sci. 1989;76:39-42.
47. Montagna G, Buzio C, Calderini C, Quaretti P, Migone L. Relationship of proteinuria and albuminuria to posture and to urine collection period. Nephron. 1983;35:143-144.
48. Feldt-Rasmussen B, Borch-Johnsen K, Deckert T, Jensen G, Jensen JS. Microalbuminuria: an important diagnostic tool. J Diabet Comp. 1994;8: 137-145.
49. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci. 1995;88:629-633.
50. Jensen JS, Borch-Johnsen K, Deckert T, Deckert M, Jensen G, Feldt-Rasmussen B. Reduced glomerular size- and charge-selectivity in clinically healthy individuals with microalbuminuria. Eur J Clin Invest. 1995;25:608-614.